Zenith Healthcare (BOM:530665) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530665 Zenith Healthcare Ltd BOM:530665
61 GF Score
Price ₹3.27
GF Value ₹3.69
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zenith Healthcare SpecialCharges?

Special Charges only applies to banks.

BOM:530665
61GF Score
Zenith Healthcare Ltd BOM:530665
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zenith Healthcare (BOM:530665) Overvalued in 2026?

Based on GuruFocus' analysis, Zenith Healthcare stock appears to be undervalued. The current stock price of ₹3.27 is trading 11.4% below its estimated GF Value™ of ₹3.69. GuruFocus considers Zenith Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:530665:

  • SpecialCharges:
  • GF Value™: ₹3.69 vs. price of ₹3.27 (11.4% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the BOM:530665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zenith Healthcare Business Description

Address Prahladnagar Cross Road, S. G. Road, 504, Iscon Elegance, Near Ananddham Jain Derasar, Ahmedabad, GJ, IND, 380051
Zenith Healthcare Ltd is an India-based pharmaceutical company engaged in the manufacturing and trading of pharmaceutical formulations. It produces a range of dosage forms, including tablets, capsules, oral liquids, and injectables, and also undertakes contract manufacturing for other pharmaceutical businesses. The company serves customers in India and exports its products to international markets. Its revenue is generated primarily through the sale of its own branded and generic formulations, as well as through contract manufacturing arrangements with domestic and overseas clients. The company operates within the broader Indian pharmaceutical sector, which is characterized by a mix of domestic formulation sales and export-oriented manufacturing.
61GF Score

Get the complete analysis for BOM:530665

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.27
Price
₹3.69
GF Value